SUSMED,Inc. (TYO:4263)

SUSMED,Inc. Income Statement

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	475	462	342	530	316	115
Revenue Growth (YoY)	38.89%	35.09%	-35.47%	67.72%	174.78%	238.24%
Cost of Revenue	14	12	12	8	11	9
Gross Profit	461	450	330	522	305	106
Selling, General & Admin	477	477	452	394	309	190
Research & Development	256	273	243	176	226	249
Operating Expenses	733	750	695	570	535	439
Operating Income	-272	-300	-365	-48	-230	-333
Other Non Operating Income (Expenses)	8	5	8	4	12	60
EBT Excluding Unusual Items	-264	-295	-357	-44	-218	-273
Gain (Loss) on Sale of Assets	-	-	-	-	-	-4
Asset Writedown	-5	-4	-2	-5	-15	-
Other Unusual Items	15	2	3	-	-	-
Pretax Income	-254	-297	-356	-49	-233	-277
Income Tax Expense	1	1	1	1	-	-
Net Income	-255	-298	-357	-50	-233	-277
Net Income to Common	-255	-298	-357	-50	-233	-277
Shares Outstanding (Basic)	17	17	17	16	15	13
Shares Outstanding (Diluted)	17	17	17	16	15	13
Shares Change (YoY)	0.50%	0.60%	1.77%	11.71%	14.76%	11.19%
EPS (Basic)	-15.17	-17.75	-21.39	-3.05	-15.87	-21.65
EPS (Diluted)	-15.17	-17.75	-21.39	-3.05	-15.87	-21.65
Free Cash Flow	-	-436	-233	94	-177	-
Free Cash Flow Per Share	-	-25.96	-13.96	5.73	-12.05	-
Gross Margin	97.05%	97.40%	96.49%	98.49%	96.52%	92.17%
Operating Margin	-57.26%	-64.94%	-106.73%	-9.06%	-72.78%	-289.56%
Profit Margin	-53.68%	-64.50%	-104.39%	-9.43%	-73.73%	-240.87%
Free Cash Flow Margin	-	-94.37%	-68.13%	17.74%	-56.01%	-
EBITDA	-264.5	-293	-360	-43	-228	-
EBITDA Margin	-55.68%	-63.42%	-105.26%	-8.11%	-72.15%	-
D&A For EBITDA	7.5	7	5	5	2	-
EBIT	-272	-300	-365	-48	-230	-333
EBIT Margin	-57.26%	-64.94%	-106.73%	-9.06%	-72.78%	-289.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.